| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2001PNAS...98.9050X |
| P356 | DOI | 10.1073/PNAS.161283798 |
| P932 | PMC publication ID | 55371 |
| P698 | PubMed publication ID | 11481471 |
| P5875 | ResearchGate publication ID | 11862487 |
| P2093 | author name string | Y Zhu | |
| Y Guo | |||
| H Han | |||
| R Bolli | |||
| Y T Xuan | |||
| P2860 | cites work | Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity | Q28248095 |
| Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor | Q28286076 | ||
| STATs and gene regulation | Q29547796 | ||
| Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway | Q29615968 | ||
| The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene | Q30454405 | ||
| Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats | Q31853215 | ||
| The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus | Q33539989 | ||
| The late phase of preconditioning | Q33926118 | ||
| Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor | Q34379342 | ||
| Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity | Q34532143 | ||
| Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines | Q36239779 | ||
| Demonstration of an early and a late phase of ischemic preconditioning in mice | Q36982103 | ||
| A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain | Q38296506 | ||
| Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide | Q38318972 | ||
| Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. | Q38344974 | ||
| An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide | Q38349380 | ||
| Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation | Q40923705 | ||
| Myocardial adaptation, stress proteins, and the second window of protection | Q41200575 | ||
| GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. | Q41404184 | ||
| Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium | Q41985628 | ||
| Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy | Q46517609 | ||
| Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte Apoptosis | Q62011116 | ||
| Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha | Q70889898 | ||
| Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes | Q71785177 | ||
| Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits | Q72993656 | ||
| Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits | Q73112776 | ||
| Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits | Q73254506 | ||
| Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide | Q73454262 | ||
| Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit | Q73542326 | ||
| The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes | Q73702843 | ||
| The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning | Q73944504 | ||
| Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction | Q74271653 | ||
| Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits | Q77133031 | ||
| Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits | Q77744396 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9050-9055 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | An essential role of the JAK-STAT pathway in ischemic preconditioning | |
| P478 | volume | 98 |
| Q44313350 | 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia |
| Q36001255 | A novel protective effect of erythropoietin in the infarcted heart |
| Q50215120 | A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathway |
| Q54568438 | Activation of STAT1 in neurons following spinal cord injury in mice. |
| Q38827605 | Activation of mitochondrial STAT-3 and reduced mitochondria damage during hypothermia treatment for post-cardiac arrest myocardial dysfunction |
| Q34974091 | Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? |
| Q44027012 | Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway |
| Q38125624 | Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning |
| Q35425229 | Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction |
| Q43170086 | An important role of increase in tetrahydrobiopterin via H2O2-JAK2 signalling pathway in late phase of ischaemic preconditioning |
| Q33292191 | CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteins |
| Q36921100 | Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium |
| Q33995071 | Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3. |
| Q35641335 | Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules |
| Q41371396 | Cardioprotective Effects of Transfusion of Late-Phase Preconditioned Plasma May Be Induced by Activating the Reperfusion Injury Salvage Kinase Pathway but Not the Survivor Activating Factor Enhancement Pathway in Rats. |
| Q57298518 | Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury |
| Q57283582 | Context-enriched interactome powered by proteomics helps the identification of novel regulators of macrophage activation |
| Q39613493 | Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. |
| Q46915202 | Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heart |
| Q34583556 | Critical role of the STAT3 pathway in the cardioprotective efficacy of zoniporide in a model of myocardial preservation – the rat isolated working heart |
| Q38143956 | Dancing rhinos in stilettos: The amazing saga of the genomic and nongenomic actions of STAT3 in the heart |
| Q37008467 | Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways |
| Q35622774 | Delayed adaptation of the heart to stress: late preconditioning |
| Q34357976 | Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling |
| Q36549642 | Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease |
| Q59810242 | Effects of Cardiovascular Risk Factors on Cardiac STAT3 |
| Q35107929 | Endoplasmic reticulum stress-dependent activation of ATF3 mediates the late phase of ischemic preconditioning |
| Q38769588 | Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse |
| Q35622787 | Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pa |
| Q92703023 | Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes |
| Q36142638 | Erythropoietin mimics ischemic preconditioning |
| Q52926879 | Erythropoietin reduces ischemia-reperfusion injury in the rat liver. |
| Q42861824 | Ethanolamine is a novel STAT-3 dependent cardioprotective agent |
| Q36569863 | Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations and mechanisms |
| Q84732981 | Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of |
| Q36015677 | H11 kinase/heat shock protein 22 deletion impairs both nuclear and mitochondrial functions of STAT3 and accelerates the transition into heart failure on cardiac overload |
| Q36895483 | High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway |
| Q41707207 | Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke |
| Q36952776 | IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. |
| Q44418962 | Impact of eight weeks of repeated ischaemic preconditioning on brachial artery and cutaneous microcirculatory function in healthy males. |
| Q35850254 | Induction of heme oxygenase-1 shifts the balance from proinjury to prosurvival in the placentas of pregnant rats with reduced uterine perfusion pressure |
| Q40897166 | Inhibition of Janus kinases by tyrosine phosphorylation inhibitor, Tyrphostin AG-490. |
| Q45012762 | Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling |
| Q46742743 | Inhibition of matrix metalloproteinase-9 by interferons and TGF-beta1 through distinct signalings accounts for reduced monocyte invasiveness |
| Q34300508 | Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion |
| Q98623397 | Inhibition of the long non-coding RNA NEAT1 protects cardiomyocytes from hypoxia in vitro via decreased pri-miRNA processing |
| Q36099027 | Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats |
| Q54463873 | Intestinal ischemic preconditioning after ischemia/reperfusion injury in rat intestine: profiling global gene expression patterns. |
| Q36732584 | Ischemic preconditioning in solid organ transplantation: from experimental to clinics |
| Q45113852 | JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells |
| Q37430884 | JAK redux: a second look at the regulation and role of JAKs in the heart |
| Q36301907 | JAK-STAT pathway in cardiac ischemic stress |
| Q37421817 | JAK-STAT signaling and myocardial glucose metabolism |
| Q28584039 | JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells |
| Q41394648 | JAK-STAT: Getting to the heart of the matter |
| Q35119530 | Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. |
| Q36923776 | Kir6.2 is not the mitochondrial KATP channel but is required for cardioprotection by ischemic preconditioning |
| Q36907315 | LIF and the heart: just another brick in the wall? |
| Q34212278 | Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore |
| Q37379567 | Loss of cardioprotection with ageing. |
| Q51102345 | Low-Dose Endotoxin Induces Late Preconditioning, Increases Peroxynitrite Formation, and Activates STAT3 in the Rat Heart. |
| Q35037331 | MG53 participates in ischaemic postconditioning through the RISK signalling pathway |
| Q35535211 | Mechanism of cyclooxygenase-2 upregulation in late preconditioning |
| Q97069866 | Myocardial ischaemia-reperfusion injury and cardioprotection in perspective |
| Q54485726 | Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury. |
| Q37522854 | Occult cardiotoxicity--toxic effects on cardiac ischemic tolerance |
| Q46065905 | Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning |
| Q54570243 | Paeoniflorin attenuates schistosomiasis japonica-associated liver fibrosis through inhibiting alternative activation of macrophages. |
| Q37361794 | Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans |
| Q38018190 | Phosphoproteomics and molecular cardiology: techniques, applications and challenges |
| Q45959541 | Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. |
| Q54731678 | Potentiation of flagellin responses in gut epithelial cells by interferon-gamma is associated with STAT-independent regulation of MyD88 expression. |
| Q37238435 | Pretreatment with bone morphogenetic protein-7 (BMP-7) mimics ischemia preconditioning following intestinal ischemia/reperfusion injury in the intestine and liver |
| Q43439841 | Protective effect of carbamazepine on kainic acid-induced neuronal cell death through activation of signal transducer and activator of transcription-3. |
| Q39826764 | Protective mechanisms of NO preconditioning against NO-induced apoptosis in H9c2 cells: role of PKC and COX-2. |
| Q44490744 | Protein Alpha Shape Similarity Analysis (PASSA): a new method for mapping protein binding sites. Application in the design of a selective inhibitor of tyrosine kinase 2. |
| Q46765499 | ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway |
| Q36392865 | Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. |
| Q46891023 | Reducing effect of IL-32α in the development of stroke through blocking of NF-κB, but enhancement of STAT3 pathways |
| Q36995201 | Regulating RISK: a role for JAK-STAT signaling in postconditioning? |
| Q42704632 | Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats |
| Q28573076 | Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells |
| Q35985573 | Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. |
| Q44068471 | Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction |
| Q91598194 | Role of interleukins in heart failure with reduced ejection fraction |
| Q36943612 | Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection |
| Q48953467 | Role of signal transducer and activator of transcription-3 in up-regulation of GFAP after epilepsy |
| Q40550480 | Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning |
| Q36895471 | Roles of STATs signaling in cardiovascular diseases |
| Q44513055 | STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning |
| Q34600271 | STAT subtype specificity and ischemic preconditioning in mice: is STAT-3 enough? |
| Q36895468 | STAT transcription in the ischemic heart |
| Q37734934 | STAT3 and cardiac remodeling |
| Q33883642 | STAT3 balances myocyte hypertrophy vis-à-vis autophagy in response to Angiotensin II by modulating the AMPKα/mTOR axis. |
| Q36099739 | Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion |
| Q34805921 | Signal transducers and activators of transcription: STATs-mediated mitochondrial neuroprotection |
| Q34150633 | Stress signaling by Tec tyrosine kinase in the ischemic myocardium |
| Q92305799 | Systems Network Genomic Analysis Reveals Cardioprotective Effect of MURC/Cavin-4 Deletion Against Ischemia/Reperfusion Injury |
| Q35635261 | Tadalafil, a Phosphodiesterase Inhibitor Protects Stem Cells over Longer Period Against Hypoxia/Reoxygenation Injury Through STAT3/PKG-I Signaling |
| Q40308442 | The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta |
| Q65002701 | The Role of the Microbiota in the Diabetic Peripheral Artery Disease. |
| Q44132497 | The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes |
| Q92077691 | The critical role of the zinc transporter Zip2 (SLC39A2) in ischemia/reperfusion injury in mouse hearts |
| Q54519859 | The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. |
| Q89871237 | The inhibition of miR-17-5p promotes cortical neuron neurite growth via STAT3/GAP-43 pathway |
| Q35987663 | The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis |
| Q36352011 | The role of erythropoietin in myocardial protection: potential mechanisms and applications |
| Q40719951 | The second window of desflurane-induced preconditioning is mediated by STAT3: role of Pim-1 kinase |
| Q38790211 | Understanding STAT3 signaling in cardiac ischemia. |
| Q37838085 | When are pro-inflammatory cytokines SAFE in heart failure? |
| Q48123240 | Whole-body hypoxic preconditioning protects mice against acute hypoxia by improving lung function |
| Q52335565 | Zinc improves mitochondrial respiratory function and prevents mitochondrial ROS generation at reperfusion by phosphorylating STAT3 at Ser727. |
| Q37608600 | gp130-mediated pathway and heart failure |
Search more.